The specific cytotoxic effects obtained in this in vitro study suggest this AIC may target and kill the majority of human primary and metastatic pancreatic cancer cells harbouring moderate to strong MUC1 overexpression. This evidence concerns the gene MUC1 and familial pancreatic carcinoma.